Principal Display Panel (54 mg Tablet Bottle Label)
Fenofibrate Tablet, Film Coated
Product Images NDC 42858-454
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 42858-454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rhodes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (160 mg Tablet Bottle Label)
NDC 42858-660-45 identifies the product as Fenofibrate tablets, which are medication used to treat high cholesterol. The rest of the text seems to be a combination of random letters and numbers, so it is not available for interpretation.*
Chemical Structure (Structure 01)
The text contains mostly structural formulas and chemical compound notations, with the mention of a molecular weight of 360.83. It doesn't provide any useful information or context for a description.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
